Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
58.3M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
24M
-
Shares change
-
+2M
-
Total reported value, excl. options
-
$14.2M
-
Value change
-
-$3.75M
-
Put/Call ratio
-
1.85
-
Number of buys
-
33
-
Number of sells
-
-36
-
Price
-
$0.59
Significant Holders of BioAtla, Inc. - Common Stock, $0.0001 par value per share (BCAB) as of Q4 2024
88 filings reported holding BCAB - BioAtla, Inc. - Common Stock, $0.0001 par value per share as of Q4 2024.
BioAtla, Inc. - Common Stock, $0.0001 par value per share (BCAB) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24M shares
of 58.3M outstanding shares and own 41.22% of the company stock.
Largest 10 shareholders include Anson Funds Management LP (4.6M shares), ACORN CAPITAL ADVISORS, LLC (4.03M shares), HIGHBRIDGE CAPITAL MANAGEMENT LLC (2.51M shares), VANGUARD GROUP INC (1.83M shares), TANG CAPITAL MANAGEMENT LLC (1.37M shares), MORGAN STANLEY (1.1M shares), MILLENNIUM MANAGEMENT LLC (1.1M shares), RENAISSANCE TECHNOLOGIES LLC (830K shares), Boxer Capital Management, LLC (686K shares), and JACOBS LEVY EQUITY MANAGEMENT, INC (648K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.